| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome.
|
Gastroenterology
|
2002
|
2.52
|
|
2
|
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
|
Gastroenterology
|
2007
|
2.30
|
|
3
|
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
|
Clin Gastroenterol Hepatol
|
2012
|
2.13
|
|
4
|
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
1.94
|
|
5
|
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.
|
Clin Gastroenterol Hepatol
|
2008
|
1.93
|
|
6
|
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function.
|
Clin Gastroenterol Hepatol
|
2009
|
1.87
|
|
7
|
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis.
|
Gastroenterology
|
2010
|
1.53
|
|
8
|
Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity.
|
Obesity (Silver Spring)
|
2009
|
1.52
|
|
9
|
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
|
Am J Gastroenterol
|
2011
|
1.33
|
|
10
|
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.
|
Gastroenterology
|
2011
|
1.22
|
|
11
|
Candidate genes and sensory functions in health and irritable bowel syndrome.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
1.19
|
|
12
|
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome.
|
Clin Gastroenterol Hepatol
|
2004
|
1.16
|
|
13
|
Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.
|
Am J Physiol Gastrointest Liver Physiol
|
2003
|
1.13
|
|
14
|
Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
1.12
|
|
15
|
Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.
|
Am J Gastroenterol
|
2005
|
1.09
|
|
16
|
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
|
Clin Gastroenterol Hepatol
|
2003
|
1.08
|
|
17
|
A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome.
|
Clin Gastroenterol Hepatol
|
2003
|
1.07
|
|
18
|
Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.
|
Am J Physiol Gastrointest Liver Physiol
|
2007
|
1.05
|
|
19
|
Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome.
|
Clin Gastroenterol Hepatol
|
2007
|
1.04
|
|
20
|
Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders.
|
Gastroenterology
|
2009
|
0.99
|
|
21
|
Obesity does not increase effects of synthetic ghrelin on human gastric motor functions.
|
Gastroenterology
|
2006
|
0.93
|
|
22
|
Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.
|
Dig Dis Sci
|
2012
|
0.90
|
|
23
|
HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome.
|
Eur J Gastroenterol Hepatol
|
2011
|
0.87
|
|
24
|
Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.
|
Dig Dis Sci
|
2010
|
0.84
|
|
25
|
Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
|
Am J Physiol Gastrointest Liver Physiol
|
2012
|
0.83
|